Table 2.
95% CI | |
---|---|
Endocrinopathy | |
Surgery | 33–41 |
fXRT/SRS | 8.8–28 |
Vascular injury | |
Surgery | 0–0.9 |
fXRT/SRS | 0 |
Neurologic deficit | |
Surgery | 3.3–7.1 |
fXRT/SRS | 0–4.6 |
Vision deterioration | |
Surgery | 2.1–5.3 |
fXRT/SRS | 3.9–13.4 |
95% CI | |
---|---|
Endocrinopathy | |
Surgery | 33–41 |
fXRT/SRS | 8.8–28 |
Vascular injury | |
Surgery | 0–0.9 |
fXRT/SRS | 0 |
Neurologic deficit | |
Surgery | 3.3–7.1 |
fXRT/SRS | 0–4.6 |
Vision deterioration | |
Surgery | 2.1–5.3 |
fXRT/SRS | 3.9–13.4 |